n-(4-Ethynylphenyl)methanesulfonamide, 90%, 2.5g

Cryolite,99.9%, 99.90%, 5g

N-ethyl-4-nitrobenzamide, 1g

5-Chloromethyl-3-(3-nitro-phenyl)-[1,2,4]oxadiazole, 97.0%, 25g

tert-Amylamine>98.0%(GC)(T)500mL

5-chloro-4H-1,2,4-triazol-3-amine hydrochloride, 95+%, 10g

2-Bromophenyl benzyl ether, 95.0%, 500g

Colonna capillare per GC ROTI®Cap-1, 30 m, 0.53 mm, 5.00 µm, 1 Pezzo(i)

2-(N-BENZYL-2,2,2-TRIFLUOROACETAMIDO)ACETIC ACID, 95.0%, 250mg

(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97% 99%ee, 500mg

1-(Cyclopropylcarbonyl)piperazine Hydrochloride>98.0%(T)5g

2-Amino-5-bromo-4-methylbenzoic acid, 97.0%, 25g

(3R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid tert-butyl ester hydrochloride, 98.0%, 250mg